Literature DB >> 11285467

Detection of immunoglobulin G in the lung and liver of hamsters with visceral leishmaniasis.

R Mathias1, F A Costa, H Goto.   

Abstract

Several organs are affected in visceral leishmaniasis, not only those rich in mononuclear phagocytes. Hypergammaglobulinemia occurs during visceral leishmaniasis; anti-Leishmania antibodies are not primarily important for protection but might be involved in the pathogenesis of tissue lesions. The glomerulonephritis occurring in visceral leishmaniasis has been attributed to immune complex deposition but in other organs the mechanism has not been studied. In the current study we demonstrated the presence of IgG in the lung and liver of hamsters with visceral leishmaniasis. Hamsters were injected intraperitoneally with 2 x 10(7) amastigotes of Leishmania (Leishmania) chagasi and the presence of IgG in the liver and lung was evaluated at 7, 15, 30, 45, 80 and 102 days postinfection (PI) by immunohistochemistry. The parasite burden in the spleen and liver increased progressively during infection. We observed a deposit of IgG from day 7 PI that increased progressively until it reached highest intensity around 30 and 45 days PI, declining at later times. The IgG deposits outlined the sinusoids. In the lung a deposit of IgG was observed in the capillary walls that was moderate at day 7 PI, but the intensity increased remarkably at day 30 PI and declined at later times of infection. No significant C3 deposits were observed in the lung or in the liver. We conclude that IgG may participate in the pathogenesis of the inflammatory process of the lung and liver occurring in experimental visceral leishmaniasis and we discuss an alternative mechanism other than immune complex deposition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285467     DOI: 10.1590/s0100-879x2001000400015

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  5 in total

1.  A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.

Authors:  Fabiana Rodrigues de Santana; Danielle Aparecida Marino da Silva; Simone Katz; Cristina Mary Orikaza; Katia Cristina Oliveira; Clara Lúcia Barbiéri
Journal:  Parasitol Res       Date:  2022-08-23       Impact factor: 2.383

2.  T cells, adhesion molecules and modulation of apoptosis in visceral leishmaniasis glomerulonephritis.

Authors:  Francisco A L Costa; Maria G Prianti; Teresa C Silva; Silvana M M S Silva; José L Guerra; Hiro Goto
Journal:  BMC Infect Dis       Date:  2010-05-11       Impact factor: 3.090

Review 3.  Role of Cytokines in Experimental and Human Visceral Leishmaniasis.

Authors:  Mukesh Samant; Utkarsha Sahu; Satish Chandra Pandey; Prashant Khare
Journal:  Front Cell Infect Microbiol       Date:  2021-02-18       Impact factor: 5.293

4.  Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.

Authors:  Nádia das Dores Moreira; Juliana Vitoriano-Souza; Bruno Mendes Roatt; Paula Melo de Abreu Vieira; Henrique Gama Ker; Jamille Mirelle de Oliveira Cardoso; Rodolfo Cordeiro Giunchetti; Cláudia Martins Carneiro; Marta de Lana; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

5.  Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis.

Authors:  Rahul Shivahare; Preeti Vishwakarma; Naveen Parmar; Pawan Kumar Yadav; Wahajul Haq; Mrigank Srivastava; Suman Gupta; Susanta Kar
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.